These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

308 related items for PubMed ID: 2951601

  • 1. Binding of 3H-spiperone and 3H-(-)-sulpiride to dopamine D2 receptors in rat striatal membranes: methodological considerations and demonstration of the identical nature of the binding sites for the two ligands.
    Urwyler S, Coward D.
    Naunyn Schmiedebergs Arch Pharmacol; 1987 Feb; 335(2):115-22. PubMed ID: 2951601
    [Abstract] [Full Text] [Related]

  • 2. Selective labelling of dopamine (D2) receptors in rat striatum by [3H]domperidone but not by [3H]spiperone.
    Lazareno S, Nahorski SR.
    Eur J Pharmacol; 1982 Jul 09; 81(2):273-85. PubMed ID: 7117377
    [Abstract] [Full Text] [Related]

  • 3. Resolution of dopamine and serotonin receptor components of [3H]spiperone binding to rat brain regions.
    List SJ, Seeman P.
    Proc Natl Acad Sci U S A; 1981 Apr 09; 78(4):2620-4. PubMed ID: 6941314
    [Abstract] [Full Text] [Related]

  • 4. Comparison of dopamine receptor sites labeled by [3H]-S-sulpiride and [3H]-spiperone in striatum.
    Zahniser NR, Dubocovich ML.
    J Pharmacol Exp Ther; 1983 Dec 09; 227(3):592-9. PubMed ID: 6655559
    [Abstract] [Full Text] [Related]

  • 5. Autoradiographic studies in animal models of hemi-parkinsonism reveal dopamine D2 but not D1 receptor supersensitivity. I. 6-OHDA lesions of ascending mesencephalic dopaminergic pathways in the rat.
    Graham WC, Crossman AR, Woodruff GN.
    Brain Res; 1990 Apr 23; 514(1):93-102. PubMed ID: 2113410
    [Abstract] [Full Text] [Related]

  • 6. Effects of heavy metal cations, sulfhydryl reagents and other chemical agents on striatal D2 dopamine receptors.
    Scheuhammer AM, Cherian MG.
    Biochem Pharmacol; 1985 Oct 01; 34(19):3405-13. PubMed ID: 3931643
    [Abstract] [Full Text] [Related]

  • 7. 3H-spiperone labels sigma receptors, not dopamine D2 receptors, in rat and human lymphocytes.
    Coccini T, Manzo L, Costa LG.
    Immunopharmacology; 1991 Oct 01; 22(2):93-105. PubMed ID: 1662188
    [Abstract] [Full Text] [Related]

  • 8. Identification of dopamine "D3" and "D4" binding sites, labelled with [3H]2-amino-6,7-dihydroxy-1,2,3,4-tetrahydronaphthalene, as high agonist affinity states of the D1 and D2 dopamine receptors, respectively.
    Urwyler S, Markstein R.
    J Neurochem; 1986 Apr 01; 46(4):1058-67. PubMed ID: 2936868
    [Abstract] [Full Text] [Related]

  • 9. Comparisons between the in vitro binding of two substituted benzamides and two butyrophenones to dopamine-D2 receptors in the rat striatum.
    Hall H, Wedel I.
    Acta Pharmacol Toxicol (Copenh); 1986 May 01; 58(5):368-73. PubMed ID: 2943136
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Dopamine D2 receptors selectively labeled by a benzamide neuroleptic: [3H]-YM-09151-2.
    Niznik HB, Grigoriadis DE, Pri-Bar I, Buchman O, Seeman P.
    Naunyn Schmiedebergs Arch Pharmacol; 1985 Jun 01; 329(4):333-43. PubMed ID: 2863760
    [Abstract] [Full Text] [Related]

  • 12. Characterization of [3H]quinpirole binding to D2-like dopamine receptors in rat brain.
    Levant B, Grigoriadis DE, DeSouza EB.
    J Pharmacol Exp Ther; 1992 Sep 01; 262(3):929-35. PubMed ID: 1356154
    [Abstract] [Full Text] [Related]

  • 13. Comparison of neuroleptic binding characteristics in rat striatum and renal cortex.
    Hietala J, Syvälahti E, Röyttä M.
    J Recept Res; 1988 Sep 01; 8(6):753-71. PubMed ID: 3193400
    [Abstract] [Full Text] [Related]

  • 14. [3H]spiperone binds selectively to rat striatal D2 dopamine receptors in vivo: a kinetic and pharmacological analysis.
    Leslie CA, Bennett JP.
    Brain Res; 1987 Mar 31; 407(2):253-62. PubMed ID: 2952221
    [Abstract] [Full Text] [Related]

  • 15. Characterization of stereospecific binding of 3H-(-) sulpiride, a selective antagonist at dopamine-D2 receptors, in rat CNS.
    Memo M, Govoni S, Carboni E, Trabucchi M, Spano PF.
    Pharmacol Res Commun; 1983 Feb 31; 15(2):191-9. PubMed ID: 6844376
    [Abstract] [Full Text] [Related]

  • 16. Kainic acid lesions of striatum and decortication reduce specific [3H]sulpiride binding in rats, so D-2 receptors exist post-synaptically on corticostriate afferents and striatal neurons.
    Theodorou A, Reavill C, Jenner P, Marsden CD.
    J Pharm Pharmacol; 1981 Jul 31; 33(7):439-44. PubMed ID: 6115030
    [Abstract] [Full Text] [Related]

  • 17. Analysis of [3H]spiperone binding sites in the rat striatum and frontoparietal cortex by means of quantitative receptor autoradiography after inactivation of dopamine receptors by N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline in vivo: selective protection by sulpiride in the striatum.
    Fuxe K, Meller E, Goldstein M, Benfenati F, Agnati LF.
    Neurosci Lett; 1986 Feb 28; 64(2):163-8. PubMed ID: 3960398
    [Abstract] [Full Text] [Related]

  • 18. Distinctions between ligand-binding sites for [3H]dopamine and D2 dopaminergic receptors characterized with [3H]spiroperidol.
    Hancock AA, Marsh CL.
    Mol Pharmacol; 1984 Nov 28; 26(3):439-51. PubMed ID: 6238230
    [Abstract] [Full Text] [Related]

  • 19. Magnesium ions reveal nanomolar potency of dopamine at [3H]spiperone labelled D-2 receptors in rat corpus striatum.
    De Vries DJ, Beart PM.
    Eur J Pharmacol; 1985 Mar 12; 109(3):417-9. PubMed ID: 3157589
    [Abstract] [Full Text] [Related]

  • 20. 6-hydroxydopamine treatments enhance behavioral responses to intracerebral microinjection of D1- and D2-dopamine agonists into nucleus accumbens and striatum without changing dopamine antagonist binding.
    Breese GR, Duncan GE, Napier TC, Bondy SC, Iorio LC, Mueller RA.
    J Pharmacol Exp Ther; 1987 Jan 12; 240(1):167-76. PubMed ID: 3100767
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.